Angimmune
Pre-clinicalSponsor of Cutaneous T-cell Lymphoma clinical trial using A-dmDT390-bisFv (UCHT1) immunomodulation therapy for T-cell, cancer, and autoimmune diseases.
Founded
2007
Focus
Small Molecules
About
Sponsor of Cutaneous T-cell Lymphoma clinical trial using A-dmDT390-bisFv (UCHT1) immunomodulation therapy for T-cell, cancer, and autoimmune diseases.
Funding History
2Total raised: $25M
Series A$20MUndisclosedSep 15, 2020
Seed$5MUndisclosedApr 15, 2018
Company Info
TypePrivate
Founded2007
LocationRockville, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile